New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release
Contact Us
Contact Us

AGC Biologics

1 min read

AGC Biologics Honored for Excellence in Development and Manufacturing

March 10, 2025 at 2:41 PM
Press Release
Read press release
Adaptimmune and AGC Biologics Partnership

2 min read

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

January 16, 2025 at 5:30 AM
Press Release
Read press release
AGC Biologics’ Cell and Gene Center of Excellence expands exosome work with new project.

2 min read

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

January 9, 2025 at 9:09 AM
Press Release
Read press release
New leadership roles to drive operational readiness and regional growth for the company in Japan

1 min read

AGC Biologics Announces Leadership Updates Amid Groundbreaking of New Yokohama Site

December 22, 2024 at 6:00 PM
Press Release
Read press release
AGC Biologics CMC Jumpstart™ Program Offers Platform Assessments

2 min read

New AGC Biologics CMC Jumpstart™ Program Offers CGT Developers Viral Vector Platform Assessments that Control Costs and Analyze Feasibility

December 18, 2024 at 9:15 AM
Press Release
Read press release
Autolus and AGC Biologics

2 min read

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®

December 11, 2024 at 9:00 AM
Press Release
Read press release

2 min read

AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer

October 28, 2024 at 3:00 AM
Press Release
Read press release
Seattle BLAs - 3 approvals in 2024

1 min read

AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

October 17, 2024 at 3:00 AM
Press Release
Read press release
AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

1 min read

AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

October 9, 2024 at 11:00 PM
Press Release
Read press release
CompleCure and AGC Biologics Chiba Project Announcement

2 min read

CompleCure Partners with AGC Biologics’ Chiba Site to Develop Advanced Anti-Cancer Therapeutic Using Pioneering AMDC Technology

September 23, 2024 at 4:45 AM
Press Release Process Development Microbial
Read press release
1 2 3 Next